Xalatan in the Treatment of Primary Open-Angle Glaucoma. Review
Over the past 25 years, Xalatan (Latanaprost) has become one of the most effective first-line drugs in the treatment of glaucoma, due to its pronounced hypotensive effect, safety and convenience of a single instillation. The review article presents the historical aspects of the creation and mechanis...
Saved in:
| Main Authors: | I. A. Loskutov, O. M. Andruhina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ophthalmology Publishing Group
2023-12-01
|
| Series: | Oftalʹmologiâ |
| Subjects: | |
| Online Access: | https://www.ophthalmojournal.com/opht/article/view/2231 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A comparative evaluation of the efficacy and safety of Latanoprost-Optic and Xalatan used as monotherapy and combined with Dorzolamide-Optic for primary open-angle glaucoma under clinical practice conditions
by: D. P. Novikov, et al.
Published: (2023-03-01) -
Hypotensive therapy effectiveness evaluation in primary open-angle glaucoma evidenced by pattern electroretinogram data
by: E. V. Tur, et al.
Published: (2023-03-01) -
The impact of prostaglandin analogues on the biomechanical parameters of corneoscleral shell in primary open angle glaucoma
by: E. N. Iomdina, et al.
Published: (2018-10-01) -
A new algorithm of treatment choice in primary open-angle glaucoma
by: A. A. Antonov, et al.
Published: (2022-01-01) -
Prospects for neuroretinoprotective therapy of glaucoma
by: A. E. Aprelev, et al.
Published: (2023-12-01)